Issue link: http://digitaleditions.uberflip.com/i/1388210
82 Maternity and Obstetrics Groups 1 & 2 (as the denominator): Single cephalic nulliparous pregnancies at greater than or equal to 37 weeks gestation. Indications for induction of labour (Group 2(a)) 1334/2814 (47.4%) Fetal 458/2814 16.3% SROM not in labour 348/2814 12.4% Maternal 214/2814 7.6% Postterm (>= 42 weeks) 118/2814 4.2% PET/Hypertension 106/2814 3.8% Postdates (>40 and less than 42 weeks) 94/2814 3.3% No medical indication 11/2814 0.4% Comment: The induction rate in single cephalic nulliparous women at term is 47.4%. This is high and a change of clinical practice partly at least as a result of changing epidemiological variables. Group 2a: Caesarean Section Rate by Indication for Induction and Indication for Caesarean Section Fetal reason (no oxytocin) IUA - Inability to treat fetal intolerance IUA - Inability to treat over contracting IUA - Poor response IUA - No oxy- tocin given EUA - Cephalopelvic disproportion EUA - Persistent malposition Fetal 169/458 (36.9%) 46/458 (10.5%) 57/458 (12.4%) 2/458 (0.4%) 45/458 (9.8%) 7/458 (1.5%) 3/458 (0.7%) 9/458 (2.0%) SROM not in labour 118/348 (33.9%) 3/348 (0.9%) 42/348 (12.1%) 0/348 (0.0%) 60/348 (17.2%) 2/348 (0.6%) 4/348 (1.1%) 7/348 (2.0%) Maternal 59/214 (27.6%) 9/214 (4.2%) 23/214 (10.7%) 1/214 (0.5%) 16/214 (7.5%) 2/214 (0.9%) 3/214 (1.4%) 5/214 (2.3%) Postterm (>= 42 weeks) 36/118 (30.5%) 4/118 (3.4%) 15/118 (12.7%) 1/118 (0.8%) 8/118 (6.8%) 2/118 (1.7%) 0/118 (0.0%) 6/118 (5.1%) PET/Hypertension 36/106 (34.0%) 5/106 (4.7%) 10/106 (9.4%) 0/106 (0.0%) 15/106 (14.2%) 6/106 (5.7%) 0/106 (0.0%) 0/106 (0.0%) Postdates (>40 and less than 42 weeks) 27/94 (28.7%) 8/94 (8.5%) 8/94 (8.5%) 0/94 (0.0%) 5/94 (5.3%) 2/94 (2.1%) 1/94 (1.1%) 3/94 (3.2%) No medical indication 4/11 (36.4%) 0/11 (0.0%) 2/11 (18.2%) 2/11 (18.2%) 0/11 (0.0%) 0/11 (0.0%) 0/11 (0.0%) 0/11 (0.0%) 2020 | NMH Annual Rep t